2026 Reports — Alamar Biosciences, Inc.

Alamar's revenue rose 82% to $29.4 million in its first quarter as a public company as consumables sales jumped 147%, lifting gross margin to 60%, but spending grew faster and the operating loss widened to $13.5 million.